Journal article
The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
Abstract
OBJECTIVE: The antimalarial medication hydroxychloroquine has been proposed as a thromboprotective agent in systemic lupus erythematosus (SLE), but studies thus far have been limited by the possibility of confounding by indication. This study was conducted to assess whether exposure to antimalarial drugs is associated with a decrease in thrombovascular events (TEs) in patients with SLE.
METHODS: The study was designed as a nested case-control …
Authors
Jung H; Bobba R; Su J; Shariati‐Sarabi Z; Gladman DD; Urowitz M; Lou W; Fortin PR
Journal
Arthritis & Rheumatism, Vol. 62, No. 3, pp. 863–868
Publisher
Wiley
Publication Date
3 2010
DOI
10.1002/art.27289
ISSN
0004-3591